scispace - formally typeset
R

Rachel Lorier

Researcher at Medical College of Wisconsin

Publications -  15
Citations -  902

Rachel Lorier is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Genotyping & Exome sequencing. The author has an hindex of 10, co-authored 15 publications receiving 806 citations.

Papers
More filters
Journal ArticleDOI

An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

TL;DR: A patient with an autoinflammatory disease in which the main clinical features are pustular rash, marked osteopenia, lytic bone lesions, respiratory insufficiency, and thrombosis is described, which contains a 175-kb homozygous deletion at chromosome 2q13, which encompasses several interleukin-1 family members.
Journal ArticleDOI

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project

TL;DR: In this paper, the Coriell cell lines were selected based on ethnic diversity and partial genotype characterization from earlier testing, and DNA samples were coded and distributed to volunteer testing laboratories for targeted genotyping using a number of commercially available and laboratory developed tests.
Journal ArticleDOI

A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.

TL;DR: Processes for incorporating pharmacogenetic tests and interpretations into the EMR for clinical practice and translating the growing number of genetic variants into interpretive consultations to facilitate gene‐based drug prescribing are described.
Journal ArticleDOI

IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy

TL;DR: A dynamic IL-10–dependent functional reciprocity between regulatory T cell subsets that maintains mucosal tolerance is identified and promoted by the niche supporting stable iTregs, which promotes a large population of ex-iTregs with pathogenic potential during immunotherapy.